These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 894682)

  • 1. Stereochemical studies on medicinal agents. 23. Synthesis and biological evaluation of 6-amino derivatives of naloxone and naltrexone.
    Jiang JB; Hanson RN; Portoghese PS; Takemori AE
    J Med Chem; 1977 Aug; 20(8):1100-2. PubMed ID: 894682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist properties.
    Portoghese PS; Larson DL; Jiang JB; Caruso TP; Takemori AE
    J Med Chem; 1979 Feb; 22(2):168-73. PubMed ID: 218009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.
    Malspeis L; Bathala MS; Ludden TM; Bhat HB; Frank SG; Sokoloski TD; Morrison BE; Reuning RH
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):43-65. PubMed ID: 810832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecific synthesis of the 6beta-hydroxy metabolites of naltrexone and naloxone.
    Chatterjie N; Inturrisi CE
    J Med Chem; 1975 May; 18(5):490-2. PubMed ID: 1151958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narcotic antagonist activity of several metabolites of naloxone and naltrexone tested in morphine dependent mice (38558).
    Fujimoto JM; Roerig S; Wang RI; Chatterjie N; Inturrisi CE
    Proc Soc Exp Biol Med; 1975 Feb; 148(2):443-8. PubMed ID: 1168347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6beta-[N,N-Bis(2-chloroethyl)amino]-17-(cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan(chlornaltrexamine) a potent opioid receptor alkylating agent with ultralong narcotic antagonist actitivty.
    Portoghese PS; Larson DL; Jiang JB; Takemori AE; Caruso TP
    J Med Chem; 1978 Jul; 21(7):598-9. PubMed ID: 209185
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones.
    Pasternak GW; Hahn EF
    J Med Chem; 1980 Jun; 23(6):674-6. PubMed ID: 6156240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure-action relationship and kinetics of some naloxone and naltrexone derivatives.
    Vizi ES; Foldes FF; Rich J; Knoll J
    Pharmacology; 1976; 14(1):76-85. PubMed ID: 959310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone.
    Porter SJ; Somogyi AA; White JM
    Addict Biol; 2002 Apr; 7(2):219-25. PubMed ID: 12006217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the hot plate technique to study narcotic antagonists.
    Heilman RD; Gray MI; Chen RP; Hahn EF; Fishman J
    Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):635-47. PubMed ID: 1265343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
    Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone.
    Shannon HE; Holtzman SG
    Psychopharmacology (Berl); 1976 Nov; 50(2):119-24. PubMed ID: 826950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine.
    Caruso TP; Larson DL; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1980 Jun; 213(3):539-44. PubMed ID: 6162947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology.
    Zádor F; Király K; Váradi A; Balogh M; Fehér Á; Kocsis D; Erdei AI; Lackó E; Zádori ZS; Hosztafi S; Noszál B; Riba P; Benyhe S; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2017 Aug; 809():111-121. PubMed ID: 28502630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF; Nishimura S; Goodman RR; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers.
    Schmidhammer H; Leander JD; Mayer-Valkanover K; Nussbaumer C; Schmidt C; Schoepp DD; Schratz A; Walla-Kugler M
    Prog Clin Biol Res; 1990; 328():41-4. PubMed ID: 2154800
    [No Abstract]   [Full Text] [Related]  

  • 17. Narcotic antagonists. 4. Carbon-6 derivatives of N-substituted noroxymorphones as narcotic antagonists.
    Heilman RD; Hahn EF; Fishman J
    J Med Chem; 1975 Mar; 18(3):259-62. PubMed ID: 1133815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereospecific accumulation of dihydromorphine and naltrexone by corpus striatal slices of morphine-dependent mice.
    Oishi R; Takemori AE
    Neuropharmacology; 1982 Jan; 21(1):57-61. PubMed ID: 6278352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrochemical chromatographic determinations of morphine antagonists in biological fluids, with applications.
    Derendorf H; El-Din A; El-Koussi A; Garrett ER
    J Pharm Sci; 1984 May; 73(5):621-4. PubMed ID: 6737235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu-opioid receptor up-regulation and functional supersensitivity are independent of antagonist efficacy.
    Sirohi S; Kumar P; Yoburn BC
    J Pharmacol Exp Ther; 2007 Nov; 323(2):701-7. PubMed ID: 17698975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.